Experimental Corynebacterium equi infection in mice. 1982

M D Mutimer, and J B Woolcock

When normal mice are challenged intravenously with Corynebacterium equi, the organisms are generally cleared from the liver, spleen and lung after an initial increase in numbers in these tissues. Viable organisms can still be recovered from the liver and spleen 5 weeks after challenge. The animals show no sign of infection even when tissue counts exceed 1 X 10(7). In-vivo growth rates of C. equi are similar when the challenge inoculum is 6 h and 21 h old. In-vitro growth temperature does not affect the pattern of in-vivo growth and clearance. There was no evidence of systemic involvement when 6 X 10(7) and 7 X 10(7) organisms were administered orally and subcutaneously, respectively. Following intranasal challenge with 1.5 X 10(6) organisms mice can clear the lungs within 4 weeks, but when challenged with 10 times this number of organisms, the clearance rate is slowed markedly and pneumonia results. Administration of carrageenan before bacterial challenge reduces clearance rates from the tissues but does not affect mortality rates. Cyclophosphamide treatment with C. equi infection converts a non-lethal challenge into a fatal infection and impairs clearance from the tissues.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D003352 Corynebacterium A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.
D003354 Corynebacterium Infections Infections with bacteria of the genus CORYNEBACTERIUM. Infections, Corynebacterium,Corynebacterium Infection,Infection, Corynebacterium
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006734 Horse Diseases Diseases of domestic and wild horses of the species Equus caballus. Equine Diseases,Disease, Equine,Disease, Horse,Diseases, Equine,Diseases, Horse,Equine Disease,Horse Disease
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M D Mutimer, and J B Woolcock
July 1980, Canadian journal of comparative medicine : Revue canadienne de medecine comparee,
M D Mutimer, and J B Woolcock
April 1968, Journal of the American Veterinary Medical Association,
M D Mutimer, and J B Woolcock
July 1981, Journal of comparative pathology,
M D Mutimer, and J B Woolcock
February 1990, The European respiratory journal,
M D Mutimer, and J B Woolcock
July 1973, Cancer,
M D Mutimer, and J B Woolcock
July 1977, American journal of clinical pathology,
M D Mutimer, and J B Woolcock
February 1980, Australian veterinary journal,
M D Mutimer, and J B Woolcock
July 1977, Equine veterinary journal,
Copied contents to your clipboard!